Hypera to acquire portfolio of brands from Sanofi

14 July 2021 - Deborah Wilkes

Premium

Brazil’s Hypera Pharma is acquiring a portfolio of OTC and prescription brands – including the analgesic AAS and the herbal medicine Naturetti – from Sanofi for USD190 million.

Click tags below for more information on topics:

Hypera Pharma Sanofi Consumer Healthcare

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: